单位:[1]Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China[2]Department of Endocrinology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China[3]Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China内科学系内分泌内科华中科技大学同济医学院附属同济医院[4]NMPA Key Laboratory for Quality Research and Evaluation of Traditional Chinese Medicine, Shenzhen Institute for Drug Control, Shenzhen, China
This research was funded by the National Natural Science Foundation of China (No. 82274231, 81973506), State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University), (CMEMR2023-B12), the Fundamental Research Funds for the Central Universities (2632023TD06), Shenzhen Science and Technology Program (No. JCYJ20220531091217040), the Natural Science Foundation for Young Scientists of Shanxi Province (No. 20210302124571), Young Talent Support Project of Jiangsu Association for Science and Technology (TJ-2022-025) and Qinglan Project of Jiangsu Province.
第一作者单位:[1]Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China
通讯作者:
通讯机构:[2]Department of Endocrinology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China[3]Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
推荐引用方式(GB/T 7714):
Cui Zekun,Gu Lifei,Liu Tao,et al.Ginsenoside Rd attenuates myocardial ischemia injury through improving mitochondrial biogenesis via WNT5A/Ca2+ pathways[J].EUROPEAN JOURNAL OF PHARMACOLOGY.2023,957:doi:10.1016/j.ejphar.2023.176044.
APA:
Cui Zekun,Gu Lifei,Liu Tao,Liu Yining,Yu Boyang...&Yang Kun.(2023).Ginsenoside Rd attenuates myocardial ischemia injury through improving mitochondrial biogenesis via WNT5A/Ca2+ pathways.EUROPEAN JOURNAL OF PHARMACOLOGY,957,
MLA:
Cui Zekun,et al."Ginsenoside Rd attenuates myocardial ischemia injury through improving mitochondrial biogenesis via WNT5A/Ca2+ pathways".EUROPEAN JOURNAL OF PHARMACOLOGY 957.(2023)